Pluri Inc. (PLUR)
NASDAQ: PLUR
· Real-Time Price · USD
4.96
0.12 (2.48%)
At close: Aug 15, 2025, 3:59 PM
4.75
-4.23%
After-hours: Aug 15, 2025, 04:00 PM EDT
2.48% (1D)
| Bid | 4.15 |
| Market Cap | 38.85M |
| Revenue (ttm) | 1.03M |
| Net Income (ttm) | -20.9M |
| EPS (ttm) | -3.63 |
| PE Ratio (ttm) | -1.37 |
| Forward PE | -1.84 |
| Analyst | Buy |
| Ask | 5.6 |
| Volume | 9,738 |
| Avg. Volume (20D) | 27,816 |
| Open | 4.78 |
| Previous Close | 4.84 |
| Day's Range | 4.60 - 4.99 |
| 52-Week Range | 3.33 - 7.13 |
| Beta | 0.76 |
About PLUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PLUR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PLUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Pluri Inc. is scheduled to release its earnings on
Sep 17, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
+4.76%
Pluri shares are trading higher after the company ...
Unlock content with
Pro Subscription
9 months ago
+11.84%
Brainstorm Cell Therapeutics and Pluri shares are trading higher after the companies entered into a memorandum of understanding to manufacture NurOwn for a Phase 3b trial in amyotrophic lateral sclerosis.
